How Medicare Part D protected-class rules limit formulary tiering, prior authorization, and step therapy for certain drugs
Private insurers run Medicare Part D plans, but Medicare rules set the boundaries. CMS explains that Part D provides outpatient prescription drug coverage through private plans approved by Medicare. Those plans use formularies and cost-sharing structures that vary by plan. Protected-class rules do not remove that control. They limit how far a plan can go with certain drugs and drug classes within the Part D benefit framework.
What “protected class” means in practice
The protected-class concept is a formulary access rule. It is designed to prevent enrollees from losing practical access to drugs in categories where treatment interruptions, switching, or limited options can create serious problems. Operationally, the rule limits a plan’s ability to exclude products in those classes from its formulary.
Still, protected-class status does not put every drug on the lowest tier or eliminate utilization management. Formulary design remains possible, but it has to preserve access within Medicare’s guardrails. A plan can structure cost sharing and apply coverage controls, provided those controls fit the rules.
How tiering is limited, but not eliminated
Tiering sorts covered drugs into different cost-sharing levels. CMS states that Part D plans use formularies and cost-sharing structures that vary by plan. Protected-class rules do not replace that model. They narrow how plans can use it for drugs in protected classes.
For anyone comparing plan options, the practical point is straightforward: a protected-class drug can still appear on a higher cost-sharing tier. Protected status is not the same as preferred status. It concerns access to coverage, not a guarantee of the lowest out-of-pocket liability on every formulary.
| Formulary tool | How it works under Part D generally | How protected-class rules change it |
|---|---|---|
| Tiering | Plans place covered drugs on different cost-sharing tiers | Plans retain tiering authority, but protected-class access rules limit outright exclusion strategies |
| Prior authorization | Plans can require clinical review before approving coverage | Use is more restricted because access protections narrow how aggressively plans can block first-line coverage |
| Step therapy | Plans can require a trial of another drug before covering the requested drug | Protected-class rules can constrain step edits where they would undermine required access |
Prior authorization is allowed in principle, but constrained in use
Prior authorization is a utilization management tool, not a denial by itself. It requires the prescriber or pharmacy to submit information showing that coverage criteria are met. KFF reports that, across Medicare Advantage, Medicaid managed care, and the federally facilitated ACA Marketplaces, insurers denied at least 1 in 8 standard prior authorization requests in available 2025 data. That is not a Part D protected-class statistic. It does show why prior authorization rules matter to patients and pharmacies when a plan uses them.
Within Part D, protected-class rules limit how prior authorization can be used against drugs in those classes. A plan can still review a request for medically appropriate use, safety, or other coverage conditions. In general, it cannot use prior authorization so broadly that the protected-class access rule becomes meaningless.
Step therapy faces similar boundaries
Step therapy is more restrictive than simple tiering because it can force a particular sequence. The member has to try another covered drug before the plan covers the one originally prescribed. Protected-class rules limit that approach when it conflicts with the obligation to maintain access to the class.
For pharmacists and benefits teams, that distinction matters. A drug can be covered and still be slowed by edits. Protected-class rules reduce that risk, but they do not guarantee that every claim will adjudicate without review. Coverage design and claims processing are related, not identical.
What this means when choosing or using a Part D plan
Part D formularies and cost sharing vary by plan, so protected-class status is best understood as an access floor. It does not promise uniform member costs or identical utilization management. When assessing coverage, check whether the drug is on the formulary, which tier applies, whether prior authorization or step therapy is listed, and what the plan’s exceptions and appeals process looks like.
People with limited income and resources can also qualify for Extra Help, which Medicare.gov and CMS describe as the Part D Low-Income Subsidy. The program can lower certain Part D costs for eligible beneficiaries, but it does not change the underlying formulary rules.
This article is for general educational purposes only. It is not medical, legal, or plan-specific coverage advice. Drug coverage decisions depend on the plan’s formulary, utilization management rules, and the patient’s clinical situation. Patients should review plan documents and speak with their prescriber, pharmacist, or plan for case-specific guidance.